ClinicalTrials.gov
public full text
Public Domain
A Study of Lasmiditan in Healthy Japanese and Caucasian Participants
The main purpose of this study is to evaluate the safety and tolerability of lasmiditan in healthy Japanese and Caucasian participants. The study will also investigate how much lasmiditan gets into the bloodstream and how long it takes the body to get rid of lasmiditan when given to Japanese and Caucasians. The study will last up to 47 days for each participant.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration#800768
- A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users#902014
- A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.#1150722
- A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects#805542
- A Study of TAK-279 in Healthy Chinese Adults#862752
Record · ID 892699
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive